Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Beyond Medical Technologies Inc C.DOCT

Alternate Symbol(s):  DOCKF

Beyond Medical Technologies Inc. is a Canada-based company. The Company has no business operations and has no revenue. The Company is seeking new business opportunities.


CSE:DOCT - Post by User

Comment by Minitaton Jan 09, 2019 12:44pm
87 Views
Post# 29206845

RE:RE:RE:Micron's Wasted Technology

RE:RE:RE:Micron's Wasted TechnologySmorgasbord, thank you for your detailed response.  Admittedly I was trying to hang on to what you were saying so I re-read it a few times.  Could it be that the NR which sets aside the redundancy, tweeks and ambiguity you refer to hinges only upon the final report of the cold weather trials, which may very well incorporate the solutions to the technical issues that you have enumerated?  If so, I believe that the delay by MWM would be justifiable (within limits).  However, it is incumbent upon MWM to inform the shareholders of the progress of the cold weather trials post-haste, without the previous ambiguity or redundancy of the past.
<< Previous
Bullboard Posts
Next >>